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1. Introduction  
Free Ca2+ is an important cell messenger involved in 
numerous processes such as muscle contraction, cell division and 
cell death.1 The effects of changing the Ca2+ concentration, 
[Ca2+], can have a wide reach, extending both within and among 
cells.1 [Ca2+] can also affect a range of different activities by 
acting selectively as a highly localized signal operating in 
subcellular regions.   The free cytosolic [Ca2+] is typically in the 
region of 100 nM at rest and increases to an averaged peak 
cellular value of <1µM when the cell is activated.2 However, to 
selectively perform multiple functions, cells localize signals to 
certain regions by creating high local [ a2+] in the range of tens 
to several hundred micromolar.3  These localized concentrations 
of Ca2+ enable the control of specific cellular activities, such as 
ion channel and transcription factor activation. In addition to high 
local concentrations in the cytoplasm, organelles such as the 
mitochondria, sarcoplasmic reticulum, endoplasmic reticulum 
and Golgi apparatus each store Ca2+ at concentrations (hundreds 
of micromolar) far above the cytoplasmic average.4  
Understanding of how [Ca2+] selectively controls cell function 
remains preliminary because of the difficulties in studying Ca2+ 
signals in specific cell regions. Therefore, there have been efforts 
to develop sensors to study localized and dynamic calcium 
concentrations.5,6,7 
As part of these efforts, we set out to develop a fluorescent 
sensor that would detect changes in the high [Ca2+] found in sub-
cellular stores.  We wanted a sensor that absorbed and emitted in 
the visible rather than UV region of the spectrum so that its use 
would disturb the system minimally, and that was ratiometric so 
that quantification was straightforward.  Above all, we wanted to 
incorporate a tag so that bioorthogonal chemistry could be used 
to attach a targeting group or to attach the sensor to 
biomolecules.  
We chose to develop a sensor using the highly selective 
octadentate binding of the Ca2+ ion by a 1s,2-bis(ortho-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) 
ligand,8,9  which has become a powerful tool for studying 
changes in [Ca2+].10-18  Recent work has focused on developing 
sensors that absorb and emit in the low-energy red and near 
infrared regions of the spectrum,14-17 both to limit damage and to 
allow the use of several different fluorophores in the same 
sample (multiplexing).18 In line with this, we decided that our 
BAPTA-based sensor should absorb and emit in the red region of 
the spectrum.  
We considered an ideal Ca2+ sensor would be fluorescent both 
with Ca2+ bound and in its unbound state, but with different 
absorption or emission wavelengths.  This would allow the [Ca2+] 
to be determined directly using the ratio of the two forms using 
the binding dissociation constant of the sensor (Kd). The use of 
such so-called ratiometric probes offers many advantages over 
traditional off/on probes such as correction for artefacts e.g. 
photobleaching and variation in probe loading.19 However, the 
development of ratiometric Ca2+ sensors has lagged behind the 
development of the traditional off/on probes. Indeed, most 
biological studies using this technique20,21 rely on the original two 
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sensors, Fura-2 and Indo-1,8,9 which both absorb in the UV 
region of the spectrum.  There are recent promising ratiometric 
probes developed by Liu et al.,13 but the area is underdeveloped. 
On the other hand, we and a few others have used Fura-Red22,23 
as a ratiometric Ca2+ sensor that is excited by visible light.  It is a 
dual excitation ratiometric probe so that [Ca2+] can easily be 
determined from the ratio of the emissions at 640 nm when 
excited at 436 nm (Ca2+-bound sensor) and when excited at 472 
nm (free sensor).23 Fura-Red’s very large Stokes shift of ~200 nm 
also allows the simultaneous use of other dyes such as Fluo-4.24 
Given these excellent properties of Fura-Red, we decided to 
adjust its binding affinity so that it could detect changes when 
[Ca2+] is high. The binding dissociation constant (Kd) should be 
midway between the starting and final [Ca2+] in the process under 
study to maximise the observable response of the sensor. Most of 
the commonly-used Ca2+ sensors have Kd values within the 
nanomolar range (e.g. Fura-Red has a Kd = 380 nM22,25), which 
makes them suitable for measuring global cytosolic [Ca2+] 
fluxes.10,11 We reasoned that a low affinity Fura-Red derivative, 
NitroAzidoFuraRed (Figure 1), could be prepared that would 
have an azido tag for bioorthogonal chemistry.26   
Fura-Red’s fluorescent properties arise from photoinduced 
charge transfer because the fluorophore is in direct conjugation 
with the BAPTA unit and that conjugation changes when the 
nitrogen lone pair turns out of plane during binding.18 We 
reasoned that the binding affinity would be decreased by 
incorporating an electron-withdrawing group on the A ring, 
which would increase the conjugation with the amino group.18  
This in turn would disfavour the rotation out of plane that is 
required for binding to Ca2+ and so lower the binding affinity, 
raising Kd.11  We wished to generate a ratiometric probe with a 
Kd in the 50-100 µM range that could be used to investigate intra-
organellar [Ca2+]. Having considered the binding affinities of 
known Ca2+ sensors10,11,27 and correlations with Hammett σ 
constants,28 we decided to incorporate a nitro group in the 
BAPTA core.29 
We also decided to incorporate an azido tag in 
NitroAzidoFuraRed because it would offer a universal site of 
attachment by bioorthogonal chemistry26 that could be used to 
incorporate a targeting group or biomolecule using copper-
catalysed or strain-promoted azide-alkyne cycloaddition 
(CuAAC16,27,30 or SPAAC31). The azido group would be attached 
through the thiohydantoin unit so that it would be distal from the 
BAPTA binding site to minimise potential interference with Ca2+ 
binding.16,27,30,31 
In summary, we had designed NitroAzidoFuraRed to be a 
low-affinity, ratiometric, Ca2+ sensor excitable with visible light 
and displaying a large Stokes shift, which would have the 
potential for attachment to targeting groups and biomolecules.  
Herein, we show how it was synthesized and present its calcium 
ion binding properties.  We also provide the first examples of 
CuAAC on thiohydantoin derivatives. 
 
 
 
Figure 1.  The design of NitroAzidoFuraRed. 
 
2. Results and Discussion 
There have been no published syntheses of low affinity Fura-
Red indicators. Our approach was to construct the BAPTA core 8 
by adapting the route of Grynkiewicz et al.9 Starting from 
hydroquinone 1, benzyl protection gave bisether 2, which was 
then converted into the nitro derivative 3. Selective deprotection 
of the ortho benzyl group was achieved using aluminium 
trichloride instead of TFA to give phenol 4 in good yield.32 
Coupling phenol 4 with known bromide 6, prepared from phenol 
5,33 gave bis-nitro compound 7 in quantitative yield. Reduction of 
the nitro groups in the presence of the benzyl ether was achieved 
using iron rather than Pt/H2.  The use of acetone as a co-solvent 
was necessary for solubility and critical to the success of this 
reaction.  The resulting diamine was then alkylated to give the 
tetraethyl ester 8 in excellent yield. 
Selective formylation of the more electron rich ring gave 
aldehyde 10, which was deprotected by hydrogenolysis to yield 
phenol 11. Construction of the benzofuran unit by alkylation with 
the diethyl acetal of bromoacetaldehyde followed by acid-
induced cyclization34 proved capricious, so we decided to 
investigate allylation of the phenol, followed by oxidative 
cleavage and cyclization.  This route to benzofuran-2-
ylcarboxaldehydes is new and there was only one literature 
example35 of an allyl group being cleaved in the presence of a 
tertiary amine. The literature example employed ozonolysis, but 
the use of osmium tetroxide/sodium periodate followed by acid 
proved satisfactory. Nitration of the A ring has to be carried out 
after construction of the BAPTA unit and deactivation of the B 
ring by the aldehyde to take advantage of the directing effect of 
the amino group,14,29,36 and experimentation showed that it was 
best performed on the allyl ether 12.  Oxidation of the nitrated 
compound 13 and cyclization then gave the desired benzofuran 
14 in modest yield over the two steps. 
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Scheme 1. 
 
The final part of the synthesis required the incorporation of 
the thiohydantoin unit (Scheme 2).  3-Azidopropylamine 15 was 
prepared by the literature method,37 converted into an 
isothiocyanate and reacted with the methyl ester of glycine to 
give thiohydantoin 16.38  Knoevenagel condensation39 with 
aldehyde 14 completed the fluorophore 17 and saponification of 
the esters gave NitroAzidoFuraRed. 
 
Scheme 2. 
 
With the desired compound in hand we next investigated the 
optical properties of the new sensor. As expected, the UV/Vis 
absorption spectra of the Ca2+ free and Ca2+ bound 
NitroAzidoFuraRed are very similar to FuraRed showing a ~25 
nm blue shift in the absorption maximum upon Ca2+ binding 
(Figure 2). The fluorescence spectra of the Ca2+ free and Ca2+ 
bound NitroAzidoFuraRed are also like FuraRed showing the 
expected emission maximum at ~630 nm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Absorption (solid line) and emission (dashed line) maxima of Ca2+-
free 43 µM NitroAzidoFuraRed (red) and Ca2+ saturated NitroFuraRed (blue) 
normalized to 1.0.  Emission spectra were obtained by excitation at 
absorption maxima at 465 nm (red) and 440 nm (blue), respectively. 
 
Having established that the probe possessed the desired 
optical properties, we turned our attention to the binding 
properties. The excitation spectra of NitroAzidoFuraRed were 
obtained with different concentrations of Ca2+ and showed a good 
isobestic point at 452 nm (Figure 3). The Kd of the probe was 
found to be 90 µM using this titration and the ratio of 
fluorescence intensities at 630 nm when excited at 420 nm and 
485 nm, following the method of Grynkiewitz et al.9 
 
 
 
 
 
 
 
 
 
 
Figure 3. Excitation spectra for NitroAzidoFuraRed with free Ca2+ 
concentrations ranging from 0 µM to 2000 µM.  The excitation bandpass 
was 5 nm and fluorescence emission collected at 630 nm (bandpass 30 nm).  
The spectra have been corrected for background fluorescence.  5 µM 
NitroAzido-FuraRed in a 100 mM KCl, 30 mM MOPS, pH7.2 buffer was 
incrementally exposed to rising [Ca2+] from 0 to 2 mM.  With increasing 
[Ca2+], fluorescence emission decreases with excitation above 452 nm and 
increases with excitation below 452 nm (arrows are drawn at 420 nm and 485 
nm). 
 
With a sensor with desirable properties in hand, we tested the 
conjugation reaction.  A model thiohydantoin derivative 18, 
prepared from thiohydantoin 16, was used to test the CuAAC 
with alkyne-tagged phenylalanine derivative 20 (Scheme 3). 
However, mixtures immediately turned red upon mixing the 
thiohydantoin with copper(I) ions and the click reaction was 
ineffective.  This is consistent with the reported formation of a 
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thiohydantion-copper complex.40  The tetracarboxylate 
BAPTA-based fluorophores are cell-impermeable and are 
generally caged as acetoxymethyl (AM) esters so that they can 
cross the plasma  membrane.41 The AM esters are hydrolysed 
rapidly by esterases inside cells to give the active Ca2+ sensors.  
This strategy has been used for FuraRed,11 which also includes 
N-acetylmethyl caging of the thiohydantoin group.  Since 
NitroAzidoFuraRed is designed to be used in cells, we 
investigated whether AM-protection of the model thiohydantoin 
would allow CuAAC.  Happily, conversion of thiohydantoin 18 
into the AM derivative 19 was followed by smooth CuAAC to 
give the triazole adduct 21, a process that occurred without the 
dramatic colour change observed previously. 
 
Scheme 3. 
 
We then decided to illustrate the conjugation reaction for 
NitroAzidoFuraRed itself.  Proteins to be retained in the 
endoplasmic reticulum (ER) of cells carry the peptide KDEL 
motif so that they are recovered from other parts of the cell and 
returned to the ER.42  Inclusion of this retention sequence has 
been used as a way of localizing compounds and nanoparticles in 
the ER.43 Therefore, we exemplified the conjugation of 
NitroAzidoFuraRed by AM protection followed by CuAAC with 
an FFKDEL peptide functionalized at the N-terminus as the 
amide of 4-pentynoic acid. Under the conditions tested above, 
this gave the penta-AM protected triazole in 42% yield. 
3. Conclusion 
In conclusion, we have prepared a Ca2+ sensor that is 
ratiometric, absorbs and emits at long wavelength, has a large 
Stokes shift, is tuned to low affinity for detection of changes in 
[Ca2+] in intracellular stores and has an azido tag for conjugation 
to allow localization in cells.  Nitration to introduce the binding-
modulator had to be carried out after the synthesis of the BAPTA 
unit and the introduction of an electron-withdrawing aldehyde, 
but before introducing the benzofuran moiety.  The benzofuran 
was then constructed using a novel allylation-oxidation-
cyclization.  Finally, the azido-tagged thiohydantoin was 
introduced by Knoevenagel reaction.  We then demonstrated the 
first CuAAC of a thiohydantoin derivative, showing that AM 
protection is critical to its success, and demonstrated its potential 
in bioconjugation by attaching an FFKDEL peptide, which 
incorporates the ER protein retention sequence.  
4. Experimental Section 
4.1 General 
All reactions under an inert atmosphere were carried out using 
oven-dried or flame dried glassware. Solutions were added via 
syringe. Dichloromethane and acetonitrile were dried where 
necessary using a solvent drying system, Puresolv TM, in which 
solvent is pushed from its storage container under low nitrogen 
pressure through two stainless steel columns containing activated 
alumina and copper. Reagents were obtained from commercial 
suppliers and used without further purification unless otherwise 
stated. Flash column chromatography was carried out using 
Fisher matrix silica 60 or using a Biotage Isolera one automated 
system. 1H and 13C NMR spectra were obtained on a Bruker 
AVIII/500 spectrometer operating at 500 and 125 MHz 
respectively or a Bruker AVIII/400 spectrometer operating at 400 
and 100 MHz respectively. All coupling constants are measured 
in Hz. DEPT was used to assign the signals in the 13C NMR 
spectra as C, CH, CH2 or CH3. EI and CI mass spectra were 
obtained using the (M Station) JEOL JMS-700 spectrometer. ESI 
spectra were collected on a Bruker MicroTOF-Q. Infra-red (IR) 
spectra were obtained on a Shimadzu FTIR-8400S spectrometer 
using attenuated total reflectance (ATR) so that the IR spectrum 
of the compound (solid or liquid) could be directly detected (thin 
layer) without any sample preparation. 
4.2 Experimental Procedures 
1,4-Bis(benzyloxy)benzene 231: 1,4-Hydroquinol 1 (40.0 g, 
363 mmol, 1.00 eq.) and benzyl chloride (101 mL, 878 mmol, 
2.42 eq.) were suspended in ethanol (268 mL). Ethanolic KOH 
(250 mL, 2.85 M) was added and the mixture stirred 
mechanically for 3 h under argon then allowed to stand for 3 
days. The mixture was quenched in H2O and the off-white 
precipitate was filtered and crystallised in eight portions (14 
g/500 mL) from boiling EtOH. The combined crystallisation 
leftovers were combined, then concentrated to give another crop 
of crystals. The combined solid was dried under vacuum to give 
ether 2 as needles (71.8 g, 68%). δH (400 MHz, CDCl3): 7.45 - 
7.28 (10H, m, OCH2Ph), 6.90 (4H, s, Ph(OBn)2), 5.01 (4H, s, 
OCH2Ph). 13C NMR (101 MHz, CDCl3) δ 153.26 (C), 137.37 
(C), 128.68 (CH), 128.02 (CH), 127.60 (CH), 115.90 (CH), 70.74 
(CH2).  Spectrsocopic data agree with lit.31 
1,4-Bis(benzyloxy)-2-nitrobenzene 331 :Nitric acid (70%) 
(19.5ml, 437.4 mmol, 2.0 eq) was added slowly to a suspension 
of hydroquinol 2 (63.5 g, 218.7 mmol, 1.0 eq.) in glacial acetic 
acid (400 mL) at 0 °C. The solution was stirred at 0 °C for 3 h, 
poured into water (~1500 ml) and the resulting precipitate filtered 
off. The precipitate was washed with water (1500ml), dissolved 
in CHCl3 (300 ml), dried over magnesium sulfate and 
concentrated under vacuum to give nitro compound 3 as a yellow 
solid. (73.04 g, 100%). m.p. 80-81 ºC (lit: 80-81 ºC44). δH (400 
MHz, CDCl3): 7.49 (1H, d, J = 3.0, H3), 7.46 - 7.30 (10H, m, 
OCH2Ph), 7.12 (1H, dd, J = 9.2, 3.1 Hz, H5), 7.05 (1H, d, J = 9.2 
Hz, H6), 5.18 (2H, s, CH2), 5.05 (2H, s, CH2). 13C NMR (101 
MHz, CDCl3) δ 152.30 (C), 146.39 (C), 135.97 (C), 135.88 (C), 
128.75 (CH), 128.70 (CH), 128.37 (CH), 128.22 (CH), 127.59 
(CH), 127.15 (CH), 121.54 (CH), 117.24, 111.18 (CH), 72.10 
(CH2), 70.94 (CH2). IR (ATR cm-1):  1520 (NO2), 1497 
(CAr=CAr), 1341 (NO2). MS (ESI+): 358 [(M+Na)+, 100]. HRMS: 
358.1034. C20H17NNaO4 requires 358.1050.   Spectroscopic data 
agree with lit.31   
4-Benzyloxy-2-nitrophenol 431: Nitroaryl 3 (4.50 g, 13.4 
mmol, 1.00 eq.) was dissolved in CHCl3 (65 mL) and stirred at 0 
°C under argon. To the mixture a suspension of AlCl3 (2.07 g, 
15.5 mmol, 1.16 eq.) in CHCl3 (10 mL) was added portionwise 
with additional CHCl3 (20 mL). The reaction was monitored by 
TLC and was complete after 15 min. The mixture was quenched 
into HCl(aq) (1 M) and extracted with DCM (x 3). The combined 
organics were dried (MgSO4), filtered and the solvent removed 
under reduced pressure. The residue was crystallised from boiling 
MeOH, then recrystallised from boiling MeOH with 5% H2O 
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 5 
added. The resulting crystals were washed (H2O), then 
partitioned between H2O and DCM. The organic layer was 
separated and the solvent removed under reduced pressure, 
giving nitrophenol 4 as a solid (1.88 g, 57%). δH (400 MHz, 
CDCl3): 10.36 (1H, s, ArOH), 7.61 (1H, d, J = 3.1 Hz, H3), 7.46 
- 7.33 (5H, m, OCH2Ph), 7.29 (1H, dd, J = 9.2, 3.1 Hz, H5), 7.10 
(1H, d, J = 9.2 Hz, H6), 5.06 (2H, s, PhCH2). 13C NMR (101 
MHz, CDCl3) δ 151.64 (C), 150.20 (C), 135.86 (C), 132.97 (C), 
128.76 (CH), 128.42 (CH), 127.88 (CH), 127.65 (CH), 120.93 
(CH), 107.19 (CH), 70.92 (CH2). IR υmax (ATR)/cm-1:  3231 (O-
H), 3123 (CAr-H), 3106 (CAr-H), 1584 (CAr=CAr), 1530 (NO2), 
1501 (CAr=CAr), 1485 (CAr=CAr), 1316 (NO2). MS (EI+): 245 (M+, 
18%), 91 (C7H7+., 100). HRMS: 245.0696. C13H11O4N requires 
245.0688. Spectroscopic data agree with lit.31   
1-(2-Bromoethoxy)-2-nitrobenzene 633: 2-Nitrophenol 5 
(3.99 g, 28.7 mmol, 1.00 eq.), 1,2-dibromoethane (7.5 mL, 87 
mmol, 3.0 eq.) and K2CO3 (4.36 g, 31.6 mmol, 1.10 eq.) were 
combined in DMF (6.0 mL) and stirred at 120 °C for 3 h under 
argon. The precipitate was filtered off and washed with DCM and 
H2O. The filtrate layers were separated and the organics were 
washed with 0.5 M NaOH(aq) and saturated brine solution. The 
organics were dried (MgSO4) and filtered, then the solvent was 
removed under reduced pressure to give the bromide 6 (4.53 g, 
65%) as a solid. m.p. 36-40 ºC (lit: 36-38 ºC45).δH (400 MHz, 
CDCl3): 7.85 (1H, dd, J = 8.3, 1.7 Hz, H6), 7.55 (1H, ddd, J = 
8.4, 7.5, 1.7 Hz, H4), 7.12 - 7.06 (2H, m, H3, H5), 4.42 (2H, t, J 
= 6.5 Hz, OCH2CH2Br), 3.68 (2H, t, J = 6.5 Hz, OCH2CH2Br). 
Data agree with lit.33    
2-Nitro-1-[2’-(4’’-benzyloxy-2’’-
nitrophenoxy)ethoxy]benzene 7: 1-(2-Bromoethoxy)-2-
nitrobenzene 6 (10.9 g, 44.3 mmol, 1.47 eq.), nitrophenol 4 (7.0 
g, 30 mmol, 1.0 eq.) and K2CO3 (3.0 g, 22 mmol, 0.7 eq.) were 
combined in dry DMF (17.0 mL) and stirred at 140 °C for 2 h 
under argon, then allowed to stir at RT for 12 h. The material was 
heated to 50 °C, and the precipitate was dissolved with dropwise 
addition of water. After 24 h stirring precipitate had formed and 
was collected by filtration. The material was then washed out in a 
mixture of acetone and hexane. The solvent was removed under 
reduced pressure and the compound dissolved in DCM then 
washed with water (x 3) and 5% LiCl(aq) solution, then the solvent 
removed from the combined organics to give the ether 7 in 
quantitative yield (12.4 g, quant). m.p. 110 -111 ºC. δH (400 
MHz, CDCl3): 7.84 (1H, dd, J = 8.1, 1.7 Hz, H-3), 7.57 (1H, ddd, 
J = 8.5, 7.4, 1.7 Hz, H-5), 7.47 - 7.32 (6H, m, OCH2Ph, H-3’’), 
7.23 - 7.19 (3H, m, H6, H5’’, H6’’), 7.12 - 7.05 (1H, m, H4), 
5.07 (2H, s, OCH2Ph), 4.52 - 4.46 (4H, m, OCH2CH2O). δC 
(CDCl3, 100 MHz): 152.95 (C), 151.956 (C), 146.37 (C), 140.63 
(C), 140.20 (C), 135.90 (C), 134.34 (CH), 128.76 (CH), 128.38 
(CH), 127.59 (CH), 125.68 (CH), 121.73 (CH), 121.24 (CH), 
118.75 (CH), 115.61 (CH), 111.04 (CH), 70.96 (CH2), 69.99 
(CH2), 68.77 (CH2). υmax (ATR)/cm-1: 3094 (CH), 2960 (CH), 
2929 (CH), 2871 (CH), 1606 (CAr=CAr), 1518 (NO2), 1497 
(CAr=CAr), 1487 (NO2), 1451 (CAr=CAr). MS (EI+): (410 M+., 
45%), 166 (O2NC6H4OCH2CH2+, 38), 122 (C4H4NO2+, 44), 91 
(PhCH2+, 100). HRMS: 410.1114. C21H18N2O7 requires M+. 
410.1114.  
2-[2’-(2’’-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline 8: 
Iron powder (8.44 g, 151.13 mmol, 7.7 eq) was added portion 
wise to a solution of dinitro compound 7 (8.05 g, 19.61 mmol, 
1.0 eq.) and ammonium chloride (6.47 g, 121.04 mmol, 6.17 eq) 
in acetone: water  (300 ml (4:1)). The suspension was stirred 
rapidly and heated to 70 ˚C under argon overnight. After cooling 
to RT the mixture was filtered through celite eluting with 
acetone, the solvent was removed under reduced pressure. The 
residue was dissolved in DCM, filtered through celite again 
eluting with dichloromethane. The dichloromethane layer was 
washed with brine, dried (MgSO4), filtered and the solvent 
removed under reduced pressure to give  diamine 8 as a solid 
(6.23 mg, 91%). m.p. 146 ˚C. δH (400 MHz, CDCl3): 7.44 - 7.34 
(4H, m, H2’’’, H3’’’, H5’’’, H6’’’) 7.33 - 7.27 (1H, m, H4’’’), 
6.86 - 6.79 (2H, m, H4’’, H6’’), 6.77 (1H, d, J = 8.7 Hz,  H3), 
6.74 - 6.68 (2H, m, H3’’, H5’’), 6.39, (1H, d, J = 2.9 Hz, H6), 
6.30 (1H, dd, J = 8.7, 2.9 Hz, H5), 4.98 (2H, s, OCH2Ph), 4.35 - 
4.27 (4H, m, OCH2CH2O), 3.83 (4H, s, NH2). δC (100 MHz, 
CDCl3): 154.37 (C), 146.26 (C), 140.85 (C), 138.24 (C), 137.47 
(C), 136.89 (C), 128.52 (CH), 127.81 (CH), 127.43 (CH), 121.94 
(CH), 118.38 (CH), 115.36 (CH), 114.31 (CH), 112.66 (CH), 
103.46 (CH), 103.10 (CH), 70.43 (CH2), 68.64 (CH2), 67.64 
(CH2). IR (ATR cm-1): 3454 (NH), 3433 (NH), 3367 (NH), 3350 
(NH), 3063 (CAr-H), 3038 (CAr-H), 2959 (C-H), 2939 (C-H), 
2886 (C-H), 1611 (CAr=CAr), 1601 (CAr=CAr), 1595 (CAr=CAr), 
1207 (C-O). MS (EI+): 350 (M+., 70%), 241 (M+ – C6H4NH2O, 
9), 215 (C13H13NO2+, 42), 214 (C13H14NO2+., 11), 136 (C8H9NO+, 
41), 91 (C7H7+, 100). HRMS: 350.1629 requires 350.1630.  
Ethyl 2-N-(2’’-{2’’’-[4’’’’-(benzyloxy)-2’’’’-N,N-(2’’’’’-
ethoxy-2’’’’’-oxoethyl)amino]phenoxy]ethoxy}phenyl)-N-(2’-
ethoxy-2’-oxoethyl)amino]acetate 9: Aniline 8 (1.80 g, 5.14 
mmol, 1.00 eq.) was dried by azeotrope twice in PhMe then 
combined under argon with NaI (2.12 g, 14.1 mmol, 2.75 eq., 
dried under vacuum at 100 ˚C for 6 h) and proton sponge (also 
dried by azeotrope in PhMe, 7.50 g, 35.0 mmol, 6.81 eq.) dry 
MeCN (10.0 mL) and ethyl bromoacetate (5.00 mL, 46.3 mmol, 
9.01 eq.) were added to the stirring mixture which was then 
heated under reflux for 24 h. The solvent was then removed 
under reduced pressure and the residue was dissolved in PhMe 
and filtered. The filtrate was washed 5 times with dilute HCl(aq), 
then the organics were then combined and the solvent removed 
under vacuum. Crystallisation (Pet. ether/EtOAc) gave the 
diamine tetraester 9 (4.00 g, quant.) as needles. m.p. 96 - 97 ºC. 
δH (400 MHz, CDCl3): 7.45 - 7.34 (4H, m, H2’’’’’, H3’’’’’, 
H5’’’’’, H6’’’’’) 7.33 - 7.28 (1H, m, H4’’’’’), 6.93 - 6.78 (4H, m, 
H3’’, H4’’, H5’’, H6’’), 6.76 (1H, d, J = 9.5 Hz,  H6’’’’), 6.50 - 
6.44 (2H, m, H3’’’’, H5’’’’), 4.97 (2H, s, OCH2Ph), 4.23 (4H, s, 
OCH2CH2O), 4.16 (4H, s, NCH2), 4.14 (4H, s, NCH2), 4.055 
(4H, q, J = 7.2 Hz, CO2CH2), 4.053 (4H, q, J = 7.2 Hz, CO2CH2), 
1.16 (6H, t, J = 7.1 Hz, CH2CH3), 1.15 (6H, t, J = 7.1 Hz, 
CH2CH3). δC (100 MHz, CDCl3): 171.60 (C), 171.42 (C), 153.61 
(C), 150.32 (C), 144.73 (C), 140.58 (C), 139.36 (C), 137.22 (C), 
128.53 (CH), 127.89 (CH), 127.53 (CH), 122.13 (CH), 121.40 
(CH), 118.96 (CH), 114.43 (CH), 113.09 (CH), 107.22 (CH), 
106.37 (CH), 70.45 (CH2), 67.81 (CH2), 67.11 (CH2),  60.80 
(CH2), 60.75 (CH2), 53.49 (CH2), 53.44 (CH2), 14.06 (CH3), 
14.03 (CH3). IR υmax (ATR)/cm-1: 2986 (CAr=CAr), 2932b 
(CAr=CAr), 1736 (CO), 1598 (CAr=CAr), 1512 (CAr=CAr). MS 
(NSI): 717 [(M+Na+), 52%], 695 [(M+H)+, 100],. HRMS: 
695.3173. C37H47O11N2 requires 695.3180.  
Ethyl 2-[(2’’-{2’’’-[4’’’’-(benzyloxy)-2’’’’-[bis(2’’’’’-
ethoxy-2’’’’’-oxoethyl)amino]5-
formylphenoxy]ethoxy}phenyl)(2’-ethoxy-2’-
oxoethyl)amino]acetate 10: Phosphorus oxychloride (6.0 ml, 
64.94 mmol, 8.0 eq) was added slowly to a solution of tetraester 
9 (5.64 g, 8.11 mmol, 1.00 eq) and pyridine (6.54 ml, 81.1 mmol, 
10.0 eq) in DMF (40 ml) at 0°C under argon. The resulting red 
solution was stirred at 0°C for 1.5 h then slowly quenched with 
cold KOH solution (1M). The solution was extracted in 
dichloromethane (3 x 70 ml), the combined organic layers were 
washed with brine (4 x 200 ml) dried over magnesium sulfate 
and concentrated under vacuum to give the aldehyde suitably 
pure to use without further purification (5.60g, 95%). m.p. 135 - 
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136 ºC. δH (400 MHz, CDCl3): 10.31 (1H, s, CHO) 7.42 - 7.31 
(5H, m, Ph), 7.29 (1H, s, H6’’’’), 6.93 - 6.79 (4H, m, H3’’, H4’’, 
H5’’ H6’’), 6.30 (1H, s,  H3’’’’), 5.10 (2H, s, OCH2Ph), 4.27 - 
4.20 (4H, m, OCH2CH2O), 4.18 (4H, s, NCH2), 4.14 (4H, s, 
NCH2), 4.06 (4H, q, J = 7.1 Hz, CO2CH2), 4.03 (4H, q, J = 7.1 
Hz, CO2CH2), 1.16 (6H, t, J = 7.2 Hz, CH2CH3), 1.14 (6H, t, J = 
7.1 Hz, CH2CH3). δC (100 MHz, CDCl3): 187.49 (CH), 171.51 
(C),  170.7051 (C),  157.34 (C),  150.19 (C), 146.44 (C), 143.96 
(C), 139.48 (C), 136.32 (C), 128.71 (CH), 128.24 (CH), 127.29 
(CH), 122.10 (CH), 121.66 (CH), 119.10 (CH), 117.98 (C), 
113.32  (CH), 110.62 (CH), 102.67 (CH), 71.10 (CH2), 67.61 
(CH2), 66.90 (CH2), 61.22 (CH2), 60.76 (CH2), 53.86 (CH2), 
53.50 (CH2), 14.07 (CH3), 14.02 (CH3). IR (ATR cm-1): 2975 
(CAr-H), 2938 (CAr-H), 2928 (CAr-H), 2873 (CAr-H), 1745 (CO), 
1718 (CO), 1662, 1598 (CAr=CAr), 1517 (CAr=CAr), 1508 
(CAr=CAr). MS (NSI): 1462 [(2M+NH4+), 6%], 761 [(M+K+), 3], 
745 [(M+Na+), 60], 740 [(M+NH4+), 45], 723 [(M+H+), 100]. 
HRMS: 723.3121 requires 723.3129, C38H47O12N2.  
Ethyl 2-{[2’’-(2’’’-{2’’’’-[bis(2’’’’’-ethoxy-2’’’’’-
oxoethyl)amino]-5’’’’-formyl-4’’’’-
hydroxyphenoxy}ethoxy)phenyl](2’-ethoxy-2’-
oxoethyl)amino}acetate 11: Palladium on carbon (10% loading 
by weight, 600 mg) was added to a solution of aldehyde 10 (2.04 
g, 2.82 mmol, 1.00 eq.) in acetic acid (30 mL). The suspension 
was flushed with H2(g) then stirred under a H2(g) atmosphere 
overnight. After this time, the solution was filtered through celite 
and the celite washed with EtOAc. The combined organic  
solvents were concentrated under vacuum. Any residual acetic 
acid was removed by toluene azeotrope to give phenol 11 as an 
off white solid. (1.75 g, 98%). m.p. 78 - 80 ºC. δH (400 MHz, 
CDCl3): 11.21 (1H, s, PhOH), 9.61 (1H, s, CHO), 6.92 (1H, s, 
H6’’’’), 6.94 - 6.82 (4H, m, H3’’, H4’’, H5’’ H6’’), 6.15 (1H, s,  
H3’’’’), 4.23 (4H, s, OCH2CH2O), 4.22 (4H, s, NCH2), 4.15 (4H, 
s, NCH2), 4.08 (4H, q, J = 7.1 Hz, CO2CH2), 4.08 (4H, q, J = 7.1 
Hz, CO2CH2), 1.19 (6H, t, J = 7.2 Hz, CH2CH3), 1.16 (6H, t, J = 
7.2 Hz, CH2CH3). δC (100 MHz, CDCl3): 193.22 (CH), 171.49 
(C),  170.37 (C),  158.82 (C),  150.17 (C), 148.32 (C), 142.72 
(C), 139.48 (C), 122.25 (CH), 121.78 (CH), 119.23 (CH), 115.90 
(CH), 113.38  (CH), 113.06 (C), 104.22 (CH), 68.23 (CH2), 
66.92 (CH2), 61.34 (CH2), 60.78 (CH2), 53.85 (CH2), 53.48 
(CH2), 14.09 (CH3), 13.97 (CH3). υmax (ATR)/cm-1: 2977 (CAr-H), 
2960 (CAr-H), 2937 (CAr-H), 2908 (CAr-H), 2877 (CAr-H), 1739 
(CO), 1630 (CO), 1507 (CAr=CAr). MS (NSI): 671 [(M+K+), 5%], 
655 [(M+Na+), 62], 650 [(M+NH4+), 22], 633 [(M+H+), 100]. 
HRMS: 633.2652. (M+H)+ C31H41O12N2 requires 633.2659.  
Ethyl 2-{[2’’-(2’’’-{2’’’’-[bis(2’’’’’-ethoxy-2’’’’’-
oxoethyl)amino]-5’’’’-formyl-4’’’’-(prop-2’’’’’’-en-1’’’’’’-
yloxy)phenoxy}ethoxy)phenyl](2’-ethoxy-2’-
oxoethyl)amino}acetate 12: Allyl bromide (6.90 ml, 79.52 
mmol, 4.0 eq) was added to a stirred suspension of phenol 11 
(12.58 g, 19.88 mmol), K2CO3 (10.99 g, 79.52 mmol, 4.0 eq) and 
KI (3.30 g, 19.88 mmol, 1.0 eq) in DMF (100 ml). The 
suspension was heated to 100 oC overnight under an atmosphere 
of argon. After cooling to RT the suspension was acidified to pH 
1 with 1M hydrochloric acid and extracted onto EtOAc (2 x 150 
ml). The combined organic layers were washed with brine (3 x 
300 ml), dried over magnesium sulfate and concentrated under 
vacuum. The resulting residue was passed though a large plug of 
silica eluting EtO2 then concentrated under vacuum. The residue 
was then recrystallised from EtO2:Hexane to give allyl ether 12 
as off white solid (11.08 g, 83%). m.p. 95-96°C. δH (500 MHz: 
CDCl3): 10.27 (1H, s, CHO), 7.27 (1H, s, H-6), 6.89-6.79 (4H, 
m, Ar-H), 6.26 (1H, s, H-3), 6.01 (1H, ddd, J = 17.2, 10.5, 5.2 
Hz, CH=CH2), 5.40 (1H, ddd, J = 17.3, 3.0, 1.5 Hz, CH=CHAHB), 
5.31 (1H, dq, J = 10.5, 1.3 Hz, CH=CHAHB), 4.56 (2H, dt, J = 
5.2, 1.5 Hz, OCH2), 4.25-4.21 (4H, m, OCH2CH2O), 4.21 (4H, s, 
2x NCH2), 4.13 (4H, s, 2x NCH2), 4.06 (4H, q, J = 7.1 Hz, 2x 
CO2CH2), 4.04 (4H, q, J = 7.1 Hz, 2x CO2CH2), 1.15 (6H, t, J = 
7.1 Hz, 2 x CH3), 1.13 (6H, t, J = 7.1 Hz, 2 x CH3). δC (126 MHz: 
CDCl3): 187.42 (CH), 171.45 (C), 170.66 (C), 157.32 (C), 150.12 
(C), 146.39 (C), 143.80 (C), 139.39 (C), 132.70 (CH), 122.02 
(CH), 121.57 (CH), 118.99 (CH), 117.92 (CH2), 117.75 (C), 
113.20 (CH), 110.55 (CH), 102.25 (CH), 69.81 (CH2), 67.54 
(CH2), 66.83 (CH2), 61.16 (CH2), 60.69 (CH2), 53.83 (CH2), 
53.42 (CH2), 14.00 (CH3), 13.94 (CH3). m/z (ESI): Found: 
695.2773. C34H44O12N2 requires (M+Na)+, 695.2786. υmax 
(ATR)/cm-1: 2987 (CH), 2868 (CH), 1745 (CO2), 1732 (CHO), 
1666 (C=C).  
Synthesis of Nitroaryl 13: Fuming nitric acid (0.10 ml of a 
stock solution in dichloromethane (0.11 ml in 1.0 ml)) was added 
slowly to a stirred solution of aldehyde 12 (165 mg, 0.24 mmol, 
1.0 eq) and acetic acid (0.2 ml) in dry dichloromethane (2.0 ml) 
at 0°C under argon. The resulting deep red coloured solution was 
stirred at 0°C for 45 min then pour into aqueous potassium 
carbonate. The product was extracted with dichloromethane (2 x 
10 ml) and the combined organics washed with brine (2 x 50 ml). 
The organic layer was dried over magnesium sulfate and 
concentrated under vacuum. The resulting residue was purified 
by column chromatography on silica elution EtOAc:Hexane 1:1 
to give aldehyde 13 as a bright yellow solid (100 mg, 57%). m.p. 
125-126°C. δH (500 MHz: CDCl3): 10.27 (1H, s, CHO), 7.82 
(1H, dd, J = 9.0, 2.5 Hz, H-4), 7.69 (1H, d, J = 2.5 Hz, H-6), 7.28 
(1H, s, H-6`), 6.68 (1H, d, J = 9.0 Hz, H-3), 6.28 (1H, s, H-3`), 
6.02 (1H, ddt, J = 17.2, 10.5, 5.2 Hz, CH=CH2), 5.39 (1H, ddd, J 
= 17.3, 3.0, 1.5 Hz, CH=CHAHB), 5.30 (1H, ddd, J = 10.6, 2.6, 
1.3 Hz, CH=CHAHB), 4.55 (2H, dt, J = 5.2, 1.4 Hz, OCH2), 4.28-
4.26 (2H, m, OCH2CH2O), 4.25-4.23 (2H, m, OCH2CH2O), 4.20 
(4H, s, 2 x NCH2), 4.19 (4H, s, 2 x NCH2), 4.12 - 4.07  (8H, m, 4 
x CO2CH2), 1.17 (12H, t, J = 7.1 Hz, 4 x CH3). δC (126 MHz: 
CDCl3): 187.32 (CH), 170.50 (C), 170.30 (C), 157.54 (C), 148.45 
(C), 146.50 (C), 145.50 (C), 143.60 (C), 140.79 (C), 132.67 
(CH), 118.42 (CH), 117.99 (CH2), 117.90 (C), 115.94 (CH), 
111.20 (CH), 108.10 (CH), 102.53 (CH), 69.85 (CH2), 67.59 
(CH2), 67.27 (CH2), 61.30 (CH2), 61.17 (CH2), 53.91 (CH2), 
53.83 (CH2), 14.04 (CH3), 14.00 (CH3). m/z (FAB): 717.4 
((M+H)+, 70%), 644.2 (100), 599.2 (40), 392.2 (70). Found: 
717.2748. C34H43O14N3 requires (M+H)+, 717.2745. υmax 
(ATR)/cm-1: 2982 (CH), 2939 (CH), 1737 (CO2), 1730 (CHO), 
1662 (C=C), 1518 (CNO2), 1327 (CNO2). 
Synthesis of  benzofuran 14: Osmium tetroxide (47 µl, 0.007 
mmol, 0.03 eq, 4% solution in water) was added to a solution of 
allyl ether 13 (179 mg, 0.249 mmol), sodium periodate (213 mg, 
0.996 mmol, 4.0 eq) and 2,6-lutidine (56 µl, 0.498 mmol, 2.0 eq) 
in dioxane:water (3:1) (4 ml). The solution was stirred under 
argon at RT overnight. The resulting bright yellow solution was 
extracted into EtOAc (2 x 20 ml). The combined organic layers 
were washed with brine (2 x 50 ml) and 1 M HCl (50ml) dried 
over magnesium sulfate and concentrated under vacuum. The 
residue was dissolved in acetic acid (2 ml) then heated to 90oC 
under argon for 1 h. After cooling the solution was neutralised 
with saturated sodium bicarbonate solution and extracted into 
EtOAc (2 x 20 ml). The combined organic layer was washed with 
brine (2 x 30 ml), dried over magnesium sulfate and concentrated 
under vacuum. The residue was recrystallised twice from MeOH 
to give benzofuran 14 as a bright yellow solid (34 mg, 19% over 
two steps). m.p. 154-155°C. δH (500 MHz: CDCl3): 9.71 (1H, s, 
CHO), 7.83 (1H, dd, J = 8.9, 2.5 Hz, H-4), 7.73 (1H, d, J = 2.5 
Hz, H-6), 7.42 (1H, d, J = 0.6 Hz, H-3’ Furan ring), 7.10 (1H, s, 
H-4’), 6.97 (1H, s, H-7’), 6.70 (1H, d, J = 9.0, H-3), 4.36-4.30 
(4H, m, OCH2CH2O), 4.22 (4H, s, 2 x NCH2), 4.20 (4H, s, 2 x 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
 7 
NCH2), 4.09 (4H, q, J = 7.1 Hz, 4 x CO2CH2), 4.06 (4H, q, J = 
7.1 Hz, 2 x CO2CH2), 1.18 (6H, t, J = 7.1 Hz, 2 x CH3), 1.14 (6H, 
t, J = 7.1 Hz, 2 x CH3). δC (126 MHz: CDCl3): 178.43 (CH), 
170.67 (C), 170.35 (C), 152.89 (C), 152.61 (C), 148.82 (C), 
148.55 (C), 145.35 (C), 143.11 (C), 140.93 (C), 120.07 (C), 
118.40 (CH), 180.08 (CH), 116.11 (CH), 108.10 (CH), 105.84 
(CH), 101.67 (CH), 67.65 (CH2), 67.63 (CH2), 61.25 (CH2), 
61.07 (CH2), 53.83 (CH2), 14.04 (CH3), 13.97 (CH3). m/z (EI): 
701.1 (M+, 40%), 628.1 (100), 600.1 (15). Found: 701.2431. 
C33H39O14N3 requires (M+), 701.2432. υmax (ATR)/cm-1: 2983 
(CH), 2937 (CH), 1739 (CO2), 1514 (CNO2), 1329 (CNO2). 
Synthesis of thiohydantoin 16: Thiocarbonyl diimidazole 
(5.87g, 32.96 mmol, 1.1 eq) was added to a solution of 1-amino-
3-azidopropane37 15 (3.00 g, 29.96 mmol, 1.0 eq) in dry CHCl3 
(50 ml) at 0 °C. The solution was warmed to RT and stirred at 
RT for a further three hours. After this time glycine methyl ester 
hydrochloride (4.51 g, 35.95 mmol, 1.2  eq) and triethylamine 
(5.0 ml, 35.95 mmol, 1.2 eq) were added and the solution heated 
to 70 °C over night under an atmosphere of argon. After cooling 
the solution was washed with 1M HCl (2 x 100 ml) dried over 
sodium sulphate and concentrated under vacuum. The deep 
purple residue was passed through a plug of silica elution 
EtOAc:Petroleum ether to give thiohydantion 16 as a orange 
solid (2.84 g, 47%). m.p. 62-65°C. δH (500 MHz: CDCl3): 7.30 
(1H, broad s, NH), 4.10 (2H, s, CH2), 3.92 (2H, t, J = 7.0 Hz, 
NCH2), 3.39 (2H, t, J = 6.6 Hz, N3CH2), 2.01 – 1.93 (2H, m, 
CH2CH2CH2). δC (126 MHz: CDCl3): 184.79 (C), 171.44 (C), 
49.02 (CH2), 48.38 (CH2), 38.85 (CH2), 27.03 (CH2). m/z (CI): 
200.0 ((M+H))+, 100%), 157.0 (M-N3, 100). Found: 200.0603. 
C6H9ON5S requires (M+H+), 200.0606. υmax (ATR)/cm-1: 3219 
(NH), 2928 (CH), 2090 (N3), 1705 (NCO), 1516 (NCS).  
Synthesis of NitroAzidoFuraRed tetraethyl ester 17: 
Piperidine (1 drop) was added to a solution benzofuran 14 (56 
mg, 0.079 mmol) and thiohydantoin 16 (24 mg, 0.119 mmol, 1.5 
eq) in EtOH (3 ml). The deep red coloured solution was heated to 
70 °C over night under an atmosphere of argon. After cooling the 
resulting solid filtered and washed with EtOH to give the azide 
17 a bright red solid (47mg, 67%). m.p. 162-165°C. δH (500 
MHz: CDCl3): 9.40 (1H, s, NH), 7.85 (1H, dd, J = 8.9, 2.4 Hz, H-
4), 7.73 (1H, d, J = 2.4 Hz, H-6), 7.03 (1H, d, J = 0.6 Hz, H-7’), 
7.01 (1H, s, H-4’), 6.92 (1H, s, H-3’ Furan ring), 6.69 (1H, d, J = 
8.9, H-3), 6.56 (1H, s, CH=C), 4.37-4.30 (4H, m, OCH2CH2O), 
4.23 (4H, s, 2 x NCH2), 4.22 (4H, s, 2 x NCH2), 4.12 (4H, q, J = 
7.2 Hz, 4 x CO2CH2), 4.07 (4H, q, J = 7.1 Hz, 2 x CO2CH2), 
4.05-4.01 (2H, m, NCH2), 3.41 (2H, t, J = 6.6 Hz, CH2N3), 2.06 – 
1.99 (2H, m, CH2CH2CH2), 1.21 (6H, t, J = 7.1 Hz, 2 x CH3),  
1.15 (6H, t, J = 7.1 Hz, 2 x CH3). δC (126 MHz: CDCl3): 176.09 
(C), 170.79 (C), 170.39 (C), 163.23 (C), 152.18 (C), 150.95 (C), 
148.59 (C), 148.54 (C), 145.34 (C), 141.05 (C), 140.90 (C), 
124.44 (C), 121.75 (C), 118.39 (CH), 116.05 (CH), 112.88 (CH), 
108.10 (CH), 105.15 (CH), 101.59 (CH), 100.23 (CH), 67.66 
(CH2), 61.27 (CH2), 61.09 (CH2), 53.83 (CH2), 48.97 (CH2), 
38.84 (CH2), 27.26 (CH2), 14.05 (CH3), 13.99 (CH3). m/z (ESI): 
905.2702 (M+Na)+, 756.2500, 724.2245. Found: 905.2623. 
C39H46O14N8S requires ((M+Na)+,), 905.2746. υmax (ATR)/cm-1: 
3315 (NH), 2978 (CH), 2939 (CH), 2098 (N3), 1745 (CO2), 1716 
C=O), 1510 (CNO2). 
Synthesis of NitroAzidoFuraRed: Potassium hydroxide (0.3 
ml of a 0.5M solution) was added to a suspension of tetraethyl 
ester 17 (7.6 mg, 8.6 µmol) in dioxane (1 ml). The solution was 
stirred at RT under an atmosphere of argon and shielded from the 
light for 3h then ater (1 ml) added and the solution stirred for a 
further 1h. After this time the red coloured solution was further 
diluted with water (15 ml), acidified with 1M hydrochloric acid 
and extracted into EtOAc (2 x10 ml). The combined organic 
layers were then washed with brine (2 x 30 ml), dried over 
sodium sulfate and concentrated under vacuum to give the 
tetraacid NitroAzidoFuraRed as a red coloured solid (5.7 mg, 
86%). δH (400 MHz: D-3 MeCN): 10.11 (1H, s, NH), 7.85 (1H, 
dd, J = 9.0, 2.5 Hz, H-4), 7.78 (1H, d, J = 2.5 Hz, H-6), 7.28 (1H, 
s, H-7’), 7.17 (1H, s, H-4’), 7.11 (1H, s, H-3’ Furan ring), 6.81 
(1H, d, J = 9.0, H-3), 6.59 (1H, s, CH=C), 4.43-4.39 (2H, m, 
OCH2CH2O), 4.37-4.32 (2H, m, OCH2CH2O), 4.25 (4H, s, 2 x 
NCH2), 4.17 (4H, s, 2 x NCH2), 3.97 (2H, t, J = 6.8 Hz, NCH2), 
3.44 (2H, t, J = 6.6 Hz, CH2N3), 1.96 (presumed 2H, m, obscured 
by MeCN).  HRMS obtained on NitroAzidoFuraRed-FFKDEL 
derivative below. 
Synthesis of Azide 18: Benzaldehyde (0.13 ml, 1.3 mmol, 1.3 
eq) and piperdine (2 drops) were added to a solution of 
thiohydantoin 16 (200 mg, 1.00 mmol) in EtOH (3 ml). The 
solution was heated to 70 °C for 4h under an atmosphere of 
argon. After cooling to R.T. the solvent was removed under 
vacuum and the residue purified by column chromatography on a 
10g SNAP ultra cartridge eluting 100% hexane increasing to 
30% EtOAc/70% Hexane to give the azide as a bright yellow 
solid (252 mg, 88%). m.p. 92-96°C. δH (500 MHz: CDCl3): 8.93 
(1H, broad s, NH), 7.49-4,39 (5H, m, Ar-H), 6.76 (1H, s, CH), 
4.01 (2H, t, J = 7.0 Hz, NCH2), 3.40 (2H, t, J = 6.7 Hz, N3CH2), 
2.01 (2H, quin, J = 6.8 Hz, CH2). δC (126 MHz: CDCl3): 177.92 
(C), 163.63 (C), 132.66 (C), 129.86 (CH), 129.51 (CH), 129.10 
(CH), 126.20 (C), 113.76 (CH), 48.92 (CH2), 38.91 (CH2), 27.19 
(CH2). m/z (ESI): 310.0721 (M+Na)+. Found: 310.0721. 
C13H13ON5SNa requires ((M+Na)+,), 310.0733. υmax (ATR)/cm-1: 
3342 (NH), 2947 (CH), 2096 (N3), 1712 (NCO), 1464 (NCS). 
Synthesis of Azide 19: Potassium carbonate (326 mg, 2.35 
mmol, 1.5 eq) was added to a solution of bromomethyl acetate 
(0.23 ml, 2.35 mmol, 1.5 eq) and azide 18 (450 mg, 1.57 mmol) 
in DMF (6 ml). The solution was stirred at RT overnight, diluted 
with water (30 ml) and extracted twice into EtOAc (15 ml). The 
combined organic layer was washed with brine (3 x 30 ml), dried 
over magnesium sulfate and concentrated under vacuum. The 
residue was purified by column chromatography on silica eluting 
EtOAc:Hexane 1:2 to give the azide as a pale brown solid (240 
mg, 42%). m.p. 70-74°C. δH (500 MHz: CDCl3): 8.14-8.12 (2H, 
m, Ar-H), 7.42-4,34 (3H, m, Ar-H), 7.00 (1H, s, CH), 5.91 (2H, 
s, OCH2), 3.63 (2H, t, J = 6.9 Hz, NCH2), 3.34 (2H, t, J = 6.5 Hz, 
N3CH2), 2.12 (3H, s, CH3), 1.87 (2H, quin, J = 6.8 Hz, CH2). δC 
(126 MHz: CDCl3): 170.45 (C), 169.57 (C), 161.60 (C), 137.48 
(C), 133.91 (C), 131.95 (CH), 130.03 (CH), 128.58 (CH), 125.40 
(CH), 61.55 (CH2), 48.37 (CH2), 38.12 (CH2), 28.03 (CH2), 20.59 
(CH3). m/z (EI): 359.3 (M+, 8%), 276.2 (30),  204.1 (100). 
Found: 359.1055. C16H17O3N5S requires (M+), 359.1052. υmax 
(ATR)/cm-1: 3026 (CH), 2943 (CH), 2098 (N3), 1747 (CO2), 
1710 (NCO), 1494 (NCS). 
Synthesis of alkyne 20: DMAP, (56 mg, 0.46 mmol, 0.1 eq.) 
was added to a solution of EDCI (1.15 g, 6.00 mmol, 1.3 eq.), 4-
pentynoic acid (500 mg, 5.10 mmol, 1.1 eq.) and L-phenylalanine 
methyl ester hydrochloride (1.00g, 4.62 mmol) in dry CH2Cl2 (20 
ml). After stirring at RT overnight under argon the solution was 
diluted with CH2Cl2 (10 ml), washed with 1M HCl (30 ml) then 
saturated NaHCO3 solution (30 ml). The solution was dried ove 
magnesium sulfate and concentrated under vacuum to give the 
alkyne as a white solid (698 mg, 58%). m.p. 88-90°C. δH (500 
MHz: CDCl3): 7.32-7.24 (3H, m, Ar-H), 7.13-7.11 (2H, m, Ar-
H), 6.15 (1H, d, J = 7.7 Hz, NH), 4.92 (1H, dt, J = 7.8, 5.8 Hz, 
CH), 3.74 (3H, s, OMe), 3.18 (1H, dd, J = 13.9, 5.8 Hz, CHAHB), 
3.11 (1H, dd, J = 13.9, 5.8 Hz, CHAHB), 2.53-2.49 (2H, m, CH2), 
2.44-2.39 (2H, m, CH2), 1.98 (1H, t, J = 2.6 Hz, CH). δC (126 
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MHz: CDCl3): 171.90 (C), 170.37 (C), 135.74 (C), 129.23 
(CH), 128.51 (CH), 127.08 (CH), 82.72 (C), 69.33 (CH), 53.10 
(CH), 52.27 (CH3), 37.83 (CH2), 35.08 (CH2), 14.61 (CH2). m/z 
(EI): 259.2 (M+, 5%), 200 (15),  162.1 (100). Found: 259.1206. 
C15H17O3N requires (M+), 259.1208. υmax (ATR)/cm-1: 3309 
(Alkyne), 3252 (NH), 1720 (CO2), 1643 (CON). 
Synthesis of triazole 21: Tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (12 mg, 0.033 mmol, 0.2 eq.) was added to 
a solution of azide 19 (60 mg, 0.167 mmol, 1.0 eq) and alkyne 20 
(130 mg, 0.50 mmol, 3.0 eq.) in degassed DMSO (1 ml). The 
solution was heated to 60 °C for 1 h. After cooling the solution 
was quenched with water (25 ml) and extracted twice with 
CH2Cl2 (8 ml). The combined organic layers were washed twice 
with brine (20 ml), dried over sodium sulfate and concentrated 
under vacuum. The residue was purified by column 
chromatography on a 10g SNAP ultra cartridge eluting 100% 
CH2Cl2 increasing to CH2Cl2:6% MeOH to give the triazole as a 
pale yellow viscous oil (83 mg, 80%). δH (500 MHz: CDCl3): 
8.15-8.13 (2H, m, Ar-H), 7.50 (1H, s, CH), 7.45-7.38 (3H, m, Ar-
H), 7.28-7.20 (3H, m, Ar-H), 7.07-7.05 (2H, m, Ar-H), 7.01 (1H, 
s, PhCH), 6.40 (1H, d, J = 7.8 Hz, NH), 5.90 (2H, s, OCH2), 4.86 
(1H, dt, J = 7.8, 6.1 Hz, NHCH), 4.33 (2H, t, J = 6.9, NCH2), 
3.69 (3H, s, OMe), 3.60 (2H, t, J = 6.8, NCH2), 3.12 (1H, dd, J = 
13.9, 5.7 Hz, CHAHB), 3.06-3.01 (3H, m, CHAHB + COCH2CH2), 
2.61 (2H, t, J = 7.3, COCH2CH2), 2.25 (2H, quin, J = 6.8 Hz, 
CH2CH2CH2), 2.13 (3H, s, CH3). δC (126 MHz: CDCl3): 171.87 
(C), 171.48 (C), 170.57 (C), 169.74 (C), 161.30 (C), 146.45 (C), 
137.34 (C), 135.83 (C), 133.83 (C), 132.04 (CH), 130.23 (CH), 
129.04 (CH), 128.61 (CH), 128.41 (CH), 126.91 (CH), 125.82 
(CH), 121.77 (CH), 61.58 (CH2), 53.06 (CH), 52.12 (CH3), 47.14 
(CH2), 37.80 (CH2), 37.66 (CH2), 35.34 (CH2), 29.46 (CH2), 
21.18 (CH2), 20.62 (CH3). m/z (ESI): 641.2137 (M+Na)+. Found: 
641.2137. C31H34O6N6S requires ((M+Na)+,), 641.2153. υmax 
(ATR)/cm-1: 3300 (NH), 3252 (NH), 1743 (CO2), 17414 (CO2), 
1664 (CON). 
 
Synthesis of NitroFuraRed-FFKDEL penta-AM:  
 
 
 
 
 
 
 
 
Hunig’s base (0.1 ml, 0.57 mmol, 112 eq) and bromomethyl 
acetate (0.1 ml, 1.02 mmol, 204 eq) were added to a solution of 
NitroAzidoFuraRed (3.9 mg, 0.005 mmol) in dry MeCN (1 ml). 
The solution was stirred at RT overnight, diluted with CH2Cl2  (7 
ml), washed with 0.5M HCl (10 ml), dried over magnesium 
sulfate and concentrated under vacuum. The residue was purified 
by column chromatography on silica eluting EtO2:CHCl3 (1:1) to 
give the product as a deep red solid which was used without 
further purification. Tetrakis(acetonitrile)copper(I) 
hexafluorophosphate (~0.3 mg, 0.0008 mmol, 0.5 eq.) was added 
to a solution of crude azide obtained from the above AM 
protection (2 mg, 0.0017 mmol, 1.0 eq) and alkyne ((4-
Pentynoyl-NH)-FFKDEL-COOH) (Eurogentec, Belgium) (4.7 
mg, 0.0053 mmol, 3.0 eq.) in degassed DMSO (0.5 ml). The 
solution was heated to 70 °C under argon for 1h, cooled to RT 
and diluted with water (5 ml) then extracted with CH2Cl2 (2 x 5 
ml). The combined organic layers were concentrated under 
vacuum and the residue purified by prep-HPLC carried out on a 
Spectrasystem P2000 using a 250 mm x 21.2 mm Gemini-NX 10 
micron C-18 column maintained at 25 °C and eluted 0.1% TFA 
(90%):acetonitrile (10%) for 10 min followed by a 10-80% 
gradient at 15 mL/min over a further 40 min. The product 
containing fractions were concentrated under vacuum to give the 
triazole as a red solid (1.5 mg, 42%).  The compound was 
characterized by LCMS (see ESI). 
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